Style | Citing Format |
---|---|
MLA | Peerfirozjaei M, et al.. "Optimized Cocktail of 90Y/177Lu for Radionuclide Therapy of Neuroendocrine Tumors of Various Sizes: A Simulation Study." Nuclear Medicine Communications, vol. 43, no. 6, 2022, pp. 646-655. |
APA | Peerfirozjaei M, Tajikmansoury MA, Geramifar P, Ghorbani R, Zarifi S, Miller C, Rahmim A (2022). Optimized Cocktail of 90Y/177Lu for Radionuclide Therapy of Neuroendocrine Tumors of Various Sizes: A Simulation Study. Nuclear Medicine Communications, 43(6), 646-655. |
Chicago | Peerfirozjaei M, Tajikmansoury MA, Geramifar P, Ghorbani R, Zarifi S, Miller C, Rahmim A. "Optimized Cocktail of 90Y/177Lu for Radionuclide Therapy of Neuroendocrine Tumors of Various Sizes: A Simulation Study." Nuclear Medicine Communications 43, no. 6 (2022): 646-655. |
Harvard | Peerfirozjaei M et al. (2022) 'Optimized Cocktail of 90Y/177Lu for Radionuclide Therapy of Neuroendocrine Tumors of Various Sizes: A Simulation Study', Nuclear Medicine Communications, 43(6), pp. 646-655. |
Vancouver | Peerfirozjaei M, Tajikmansoury MA, Geramifar P, Ghorbani R, Zarifi S, Miller C, et al.. Optimized Cocktail of 90Y/177Lu for Radionuclide Therapy of Neuroendocrine Tumors of Various Sizes: A Simulation Study. Nuclear Medicine Communications. 2022;43(6):646-655. |
BibTex | @article{ author = {Peerfirozjaei M and Tajikmansoury MA and Geramifar P and Ghorbani R and Zarifi S and Miller C and Rahmim A}, title = {Optimized Cocktail of 90Y/177Lu for Radionuclide Therapy of Neuroendocrine Tumors of Various Sizes: A Simulation Study}, journal = {Nuclear Medicine Communications}, volume = {43}, number = {6}, pages = {646-655}, year = {2022} } |
RIS | TY - JOUR AU - Peerfirozjaei M AU - Tajikmansoury MA AU - Geramifar P AU - Ghorbani R AU - Zarifi S AU - Miller C AU - Rahmim A TI - Optimized Cocktail of 90Y/177Lu for Radionuclide Therapy of Neuroendocrine Tumors of Various Sizes: A Simulation Study JO - Nuclear Medicine Communications VL - 43 IS - 6 SP - 646 EP - 655 PY - 2022 ER - |